Sansure Biotech (SHSE:688289) Price-to-Operating-Cash-Flow : 317.34 (As of May. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Sansure Biotech's share price is ¥20.31. Sansure Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.06. Hence, Sansure Biotech's Price-to-Operating-Cash-Flow Ratio for today is 317.34.

The historical rank and industry rank for Sansure Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:688289' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.11 Med: 9.5 Max: 321.88
Current: 317.5

During the past 7 years, Sansure Biotech's highest Price-to-Operating-Cash-Flow Ratio was 321.88. The lowest was 5.11. And the median was 9.50.

SHSE:688289's Price-to-Operating-Cash-Flow is ranked worse than
98.64% of 441 companies
in the Medical Devices & Instruments industry
Industry Median: 21.1 vs SHSE:688289: 317.50

Sansure Biotech's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥-0.22. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.06.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sansure Biotech was -98.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -75.10% per year.

During the past 7 years, Sansure Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 370.40% per year. The lowest was -75.10% per year. And the median was 147.65% per year.

Sansure Biotech Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sansure Biotech's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Price-to-Operating-Cash-Flow Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

16.10

12.50

5.02

264.19

Sansure Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															7.37	6.51	8.44	264.19	301.56

Competitive Comparison of Sansure Biotech's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Sansure Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sansure Biotech's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sansure Biotech's Price-to-Operating-Cash-Flow falls into.

Sansure Biotech Price-to-Operating-Cash-Flow Calculation

Sansure Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	20.31	/	0.064
	=	317.34

Sansure Biotech's Share Price of today is ¥20.31.
Sansure Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.06.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Sansure Biotech Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech (SHSE:688289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Sansure Biotech (SHSE:688289) Headlines

No Headlines